Granulocyte Macrophage Colony Stimulating Factor

<strong>Human Granulocyte-Macrophage Colony Stimulating Factor </strong>_x000D_ <strong>Catalog number:</strong> B2010269_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Volume/Weight:</strong> 10 ug_x000D_ <strong>pH:</strong> n/a_x000D_ <strong>Supplied as:</strong> Reconstitute before use_x000D_ <strong>Appearance:</strong> Solid_x000D_ <strong>Applications:</strong> highly pure recombinant human Granulocyte_Macrophage Colony Stimulating Factor (expressed in CHO cells). Interleukin 2 (IL-2) is a cytokine secreted by activated T cells that plays crucial roles in the differentiation and proliferation of lymphoid cells._x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> rHuGM-CSF; CSF-2; MGI-1GM; Pluripoietin-alpha; Molgramostin; Sargramostim, GMCSF_x000D_ <strong>Grade:</strong> Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered on a 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Brem H, Howell R, Criscitelli T, Senderowicz A, Siegart N, Gorenstein S,_x000D_ Gillette B. Practical Application of Granulocyte_Macrophage Colony-Stimulating_x000D_ Factor (GM-CSF) in Patients with Wounds. Surg Technol Int. 2018 Jun 1;32:61-66._x000D_ _x000D_ 2: Denson LA, Klein C. Granulocyte_Macrophage Colony Stimulating Factor_x000D_ Bioactivity and Mucosal Homeostasis in Crohn's Disease: A Role for Genetic_x000D_ Variation. Gastroenterology. 2016 Oct;151(4):593-6._x000D_ _x000D_ 3: Vanitha S, Chaubey N, Ghosh SS, Sanpui P. Recombinant human granulocyte_macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-_x000D_ mediated delivery in cancer immunotherapy. Bioengineered. 2017 Mar_x000D_ 4;8(2):120-123._x000D_ _x000D_ 4: Gough NM, Nicola NA. Granulocyte-macrophage colony-stimulating factor._x000D_ Immunol Ser. 1990;49:111-53._x000D_ _x000D_ 5: Wu F, Dai L, Geng L, Zhu H, Jin T. Practically feasible production of_x000D_ sustained-release microspheres of granulocyte_macrophage colony-stimulating_x000D_ factor (rhGM-CSF). J Control Release. 2017 Aug 10;259:195-202._x000D_ _x000D_ 6: Chong J, Cohen M, Waubant E. Multiple sclerosis onset after granulocyte_x000D_ macrophage colony-stimulating factor withdrawal. Mult Scler Relat Disord. 2018_x000D_ Feb;20:178-180._x000D_ _x000D_ 7: Mellstedt H, Fagerberg J, Frödin JE, Henriksson L, Hjelm-Skoog AL, Liljefors_x000D_ M, Ragnhammar P, Shetye J, Osterborg A. Augmentation of the immune response with_x000D_ granulocyte_macrophage colony-stimulating factor and other hematopoietic growth_x000D_ factors. Curr Opin Hematol. 1999 May;6(3):169-75._x000D_ _x000D_ 8: Heinzelman P, Carlson SJ, Cox GN. Cytokine refacing effect reduces_x000D_ granulocyte macrophage colony-stimulating factor susceptibility to antibody_x000D_ neutralization. <a href="https://pubmed.ncbi.nlm.nih.gov/25855658/">Protein Eng Des Se</a>l. 2015 Oct;28(10):461-6._x000D_ _x000D_ <strong>Products Related to Human Granulocyte-Macrophage Colony Stimulating Factor: </strong><a href="https://moleculardepot.com/product-category/sars-cov-2/">COVID-19</a>